| Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease UA Khan, L Liu, FA Provenzano, DE Berman, CP Profaci, R Sloan, ... Nature neuroscience 17 (2), 304-311, 2014 | 664 | 2014 |
| The blood–brain barrier in health and disease: Important unanswered questions CP Profaci, RN Munji, RS Pulido, R Daneman Journal of Experimental Medicine 217 (4), 2020 | 606 | 2020 |
| Engineered Wnt ligands enable blood-brain barrier repair in neurological disorders M Martin, S Vermeiren, N Bostaille, M Eubelen, D Spitzer, M Vermeersch, ... Science 375 (6582), eabm4459, 2022 | 125 | 2022 |
| Neuronal activity regulates blood-brain barrier efflux transport through endothelial circadian genes RS Pulido, RN Munji, TC Chan, CR Quirk, GA Weiner, BD Weger, ... Neuron 108 (5), 937-952. e7, 2020 | 124 | 2020 |
| Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family JH Neale, RT Olszewski, D Zuo, KJ Janczura, CP Profaci, KM Lavin, ... Journal of neurochemistry 118 (4), 490-498, 2011 | 116 | 2011 |
| NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia RT Olszewski, KJ Janczura, SR Ball, JC Madore, KM Lavin, J Lee, MJ Lee, ... Translational Psychiatry 2 (7), e145-e145, 2012 | 61 | 2012 |
| Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege Y Ma, D Sannino, JR Linden, S Haigh, B Zhao, JB Grigg, P Zumbo, ... The Journal of Clinical Investigation 133 (9), 2023 | 40 | 2023 |
| The effects of healthy aging on the mnemonic benefit of survival processing CM Stillman, JH Coane, CP Profaci, JH Howard, DV Howard Memory & Cognition 42, 175-185, 2014 | 37 | 2014 |
| 3D visualization of the temporal and spatial spread of tau pathology reveals extensive sites of tau accumulation associated with neuronal loss and recognition memory deficit in … H Fu, SA Hussaini, S Wegmann, C Profaci, JD Daniels, M Herman, ... PLoS One 11 (7), e0159463, 2016 | 33 | 2016 |
| Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and d-amphetamine models of schizophrenia CP Profaci, KA Krolikowski, RT Olszewski, JH Neale Psychopharmacology 216, 235-243, 2011 | 31 | 2011 |
| Engineered Wnt ligands enable blood-brain barrier repair in neurological disorders. Science 375, eabm4459 M Martin, S Vermeiren, N Bostaille, M Eubelen, D Spitzer, M Vermeersch, ... | 15 | 2022 |
| Microglia are not necessary for maintenance of blood-brain barrier properties in health, but PLX5622 alters brain endothelial cholesterol metabolism CP Profaci, SS Harvey, K Bajc, TZ Zhang, DA Jeffrey, AZ Zhang, ... Neuron 112 (17), 2910-2921. e7, 2024 | 7 | 2024 |
| Lessons from the Stories of Women in Neuroscience LJ Sibener, MA Kirchgessner, S Steiner, C Santiago, D Cassataro, ... Journal of Neuroscience 42 (24), 4769-4773, 2022 | 4 | 2022 |
| Activity-dependent regulation of vascular cholesterol metabolism acts as a negative feedback mechanism for neurovascular coupling CP Profaci, KL Foreman, L Spieth, V Coelho-Santos, SA Berghoff, ... bioRxiv, 2024.02. 23.581685, 2024 | | 2024 |
